Ellis Woolcott & Associates Pty Ltd

Status: Registered
Australian Company Number: 111807286
Australian Business Number: 86111807286
Registration date: 2004-11-15
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Ellis Woolcott & Associates Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2047 since 2019-12-06 the company is, as the updated on 2021-02-12 ABN database shows, registered. Known company numbers for Ellis Woolcott & Associates Pty Ltd are as follows: ACN - 111807286, Australian Business Number - 86111807286. This company had suspended their activity from 2021-02-12 to 2021-02-12. This Australian proprietary company was previously located in NSW 2047 (from 2014-09-22 to 2019-12-06), NSW 2047 (from 2014-01-15 to 2014-09-22), NSW 2047 (from 2004-11-15 to 2014-01-15).

Details for ABN 86111807286

Type: Australian Private Company

ABN Status

Status From To
Cancelled 2021-02-12 current
Active 2004-11-15 2021-02-12

Main Name

Name From To
Ellis Woolcott & Associates Pty Ltd 2004-11-15 current

Main Location

Location From To
NSW 2047 2019-12-06 current
NSW 2047 2014-09-22 2019-12-06
NSW 2047 2014-01-15 2014-09-22
NSW 2047 2004-11-15 2014-01-15

Advertisements

Find company

NSW 2047 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.